AN2 Therapeutics financial statements

AN2 테라퓨틱스NASDAQ:ANTX · Nasdaq · Healthcare · sector #17
$5.07-9.63%
2026-10-06 close

AN2 Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$57M.

Reported results

AN2 Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q